Evidence map›Paper›PMID 41421362›Full record

ArticleAmerican journal of human genetics2026

MIRAGE: A Bayesian statistical method for gene-level rare-variant analysis incorporating functional annotations.

Shengtong Han, Xiaotong Sun, Laura Sloofman, F Kyle Satterstrom, Xizhi Xu, Lifan Liang, Nicholas Knoblauch, Wenhui Sheng, Siming Zhao, Tan-Hoang Nguyen and 4 more

Abstract read
In one paragraph

Article in American journal of human genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Shengtong HanSchool of Dentistry, Marquette University, Milwaukee, WI, USA; Department of Human Genetics, University of Chicago, Chicago, IL, USA. Electronic address: shengtong.han@marquette.edu.
Xiaotong SunDepartment of Human Genetics, University of Chicago, Chicago, IL, USA.
Laura SloofmanSeaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
F Kyle SatterstromProgram in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA; Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Xizhi XuDepartment of Human Genetics, University of Chicago, Chicago, IL, USA.
Lifan LiangDepartment of Human Genetics, University of Chicago, Chicago, IL, USA.
Nicholas KnoblauchDepartment of Human Genetics, University of Chicago, Chicago, IL, USA.
Wenhui ShengDepartment of Mathematical and Statistical Sciences, Marquette University, Milwaukee, WI, USA.
Siming ZhaoDepartment of Biomedical Data Science, Dartmouth College, Hanover, NH, USA.
Tan-Hoang NguyenVirginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA, USA.
Gao WangDepartment of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York City, NY, USA.
Autism Sequencing ConsortiumGrossman Institute for Neuroscience, Quantitative Biology and Human Behavior, University of Chicago, Chicago, IL, USA.
Joseph BuxbaumSeaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Xin HeDepartment of Human Genetics, University of Chicago, Chicago, IL, USA; Grossman Institute for Neuroscience, Quantitative Biology and Human Behavior, University of Chicago, Chicago, IL, USA. Electronic address: xinhe@uchicago.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rare-variant analysis is commonly used in whole-exome or genome sequencing studies. Compared to common variants, rare variants tend to have larger effect sizes and often directly point out causal genes. These potential benefits make association analysis with rare variants a priority for human genetics researchers. To improve the power of such studies, numerous methods have been developed to aggregate information of all variants of a gene. However, these gene-based methods often make unrealistic assumptions, e.g., the commonly used burden test effectively assumes that all variants chosen in the analysis have the same effects. In practice, current methods are often underpowered. We propose a Bayesian method: mixture-model-based rare-variant analysis on genes (MIRAGE). MIRAGE analyzes summary statistics (i.e., variant counts from inherited variants in trio sequencing or from ancestry-matched case-control studies). MIRAGE captures the heterogeneity of variant effects by treating all variants of a gene as a mixture of risk and non-risk variants and uses external information of variants to model the prior probabilities of being risk variants. We demonstrate, in both simulations and analysis of an exome-sequencing dataset of autism, that MIRAGE significantly outperforms current methods for rare-variant analysis. The top genes identified by MIRAGE are highly enriched with known or plausible autism-risk genes.

Indexed as

Genetic VariationMolecular Sequence AnnotationAutism Spectrum DisorderBayes TheoremCase-Control StudiesComputer SimulationExome SequencingGenetic Predisposition to DiseaseHumansModels, Geneticautismrare variantswhole-exome sequence

Identifiers

PMID41421362
PMCPMC12824616

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.